To ensure the protection of Charleston Laboratories’ products and technologies, we are continually expanding our intellectual property portfolio that is built around a combination of patents, copyrights, trademarks, and trade secrets.
Our primary focus is securing broad patent protection for each of our products in the major markets where we intend to commercialize either directly or with our partners. We have developed an extensive portfolio of patents and patent applications with this goal in mind.
Our patent rights cover multiple facets of our product and enabling technologies, including:
Currently, Charleston Laboratories has patents issued and pending patent applications in the US, Europe, and Japan, along with multiple other jurisdictions.
To protect our products from competition within the US, all relevant patents will be listed in the FDA Orange Book.
To further build our portfolio, Charleston Laboratories is always exploring opportunities to acquire additional technology rights and intellectual properties that complement our product pipeline and intellectual property strategy.